Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.7 2013 Stock Option Plan
- 4.4 License Agreement with Globe Labs Inc., Dated October 22, 2013
- 15.1 Independent Auditor?s Report, Issued by James Stafford,
- 15.2 Consent of Independent Registered Public Accounting Firm, Issued by James Stafford, Chartered Accountants
- 15.3 Independent Auditor?s Report, Issued by Leed Advisors Inc., Chartered Accountants
- 15.4 Consent of Independent Registered Public Accounting Firm, Issued by Leed Advisors Inc., Chartered Accountants
- 15.5 Annual Financial Statements As of December 31, 2013 , 2012 and 2011
- 15.6 Management's Discussion and Analysis for the Year Ended December 31, 2013
TOWTF similar filings
Filing view
External links
EXHIBIT 15.4
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion of our report dated April 29, 2013, except as to Notes 7, 11 and 16, which are dated October 10, 2013, with respect to the statement of financial position of Pacific Therapeutics Ltd as of December 31, 2012, and the statements of comprehensive loss, changes in equity and statement of cash flows for the year then ended, which report appears in Form 20-F of Pacific Therapeutics Ltd.
/s/ Leed Advisors Inc.
Leed Advisors Inc.
Chartered Accountants
Surrey, British Columbia
April 30, 2014